NCT05944887View on ClinicalTrials.gov

Intravenous Lidocaine to Reduce Propofol Consumption During Gastroscopy.

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

July 21, 2023

Primary Completion Date

August 21, 2023

Study Completion Date

August 25, 2023

Conditions
Diagnostic Gastroscopy
Interventions
DRUG

Lidocaine 2% Injectable Solution

administration of a bolus of lidocaine 1.5 mg/kg

DRUG

Saline administration as placebo

administration of a bolus of saline solution as a placebo

DRUG

Propofol injection

Sedation by total intravenous administration (TIVA) of propofol

PROCEDURE

gastroscopy

esogastroduodenoscopy

Trial Locations (1)

1070

Erasme Hospital, Brussels

All Listed Sponsors
lead

Erasme University Hospital

OTHER

NCT05944887 - Intravenous Lidocaine to Reduce Propofol Consumption During Gastroscopy. | Biotech Hunter | Biotech Hunter